Filing Flows › 8-K events › JBS N.V.
JBS N.V.: unregistered sales of equity securities
Form 8-K filed Nov 9, 2026 · items 3.02, 7.01, 8.01
Mergers and acquisitionsJBS Enters Personal Care Market with Flora Acquisition
What the filing says
The disclosure set forth in Item 8.01 below regarding the Purchase Agreements (as defined below) and the equity consideration payable in the Transactions (as defined below) is incorporated by reference into this Item 3.02. The Class A Shares (as defined below), including the Class A Shares underlying the BDRs (as defin
Read the filing on SEC EDGAR →
What usually followsAcross 2,752 8-Ks reporting Item 3.02 (unregistered sale of equity) in our universe, the stock's median move the next session was +0.2% (typical size ±2.1%, up 52% of the time); over the following 21 sessions, +0.5%. Item 8.01: +0.1% next session across 44,918. Every item ranked →
JBS N.V. at a glance
JBS N.V., Q3 2026: revenue $22.7B (+0.6% year over year), operating margin 2.3%. The chart follows the revenue to costs, profit and cash.
JBS N.V.: every quarter, Q/Q and Y/Y, holders and guidance →
Other recent mergers and acquisitions
- Zymeworks Nov 9, 2026
- loanDepot Nov 9, 2026
- Empery Digital Nov 9, 2026
- Ranger Energy Services Nov 9, 2026
- Harrow Nov 9, 2026
- Strive Nov 9, 2026
- Reliance Global Group Nov 9, 2026
- CDT Equity Nov 9, 2026
- Inflection Point Acquisition Corp. VI Nov 9, 2026
- Jasper Therapeutics Nov 9, 2026
Read automatically from SEC EDGAR (13F, Form 4, Form 144, Schedule 13D/G, 8-K, XBRL), House and Senate disclosures, FINRA and exchange data; errors are possible. Not investment advice.